No Prescription |
 |
 | ||
|
DIATAAL GENERIC MULTI VITAMIN |
|
| ||
No Prescription » Prescription Drugs 6 » DIATAAL GENERIC MULTI VITAMIN This medication is a multivitamin product used to treat or prevent vitamin deficiency due to poor diet certain illnesses or during pregnancy. Vitamins are important building blocks of the body and help keep you in good health.How to use Multivitamin OralTake this medication by mouth usually once daily or as directed. Follow all directions on the product package or take as directed by your doctor. Do not take more than the recommended dosage. If you are uncertain about any of the information consult your doctor or pharmacist.Take this medication regularly in order to get the most benefit from it. To help you remember take it at the same time each day.What conditions does this medication treat?Multivitamin Oral is used to treat the following:Lack in Vitamins Treatment To Prevent Vitamin Deficiency Buy DIATAAL GENERIC MULTI VITAMIN and other Prescription Drugs 6 products online at Medstore. Buy Online at Medstore - Click Here!
About DIATAAL GENERIC MULTI VITAMIN: Product Type: Prescription Drugs 6 DIATAAL ( GENERIC MULTI VITAMIN ) DIATAAL (GENERIC MULTI VITAMIN) GENERIC MULTI VITAMIN 100MG 150 Capsules 4 x 150 Capsules 2 x 150 Capsules GENERIC MULTI VITAMIN DIATAAL
View more Prescription Drugs 6 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
